The FDA has issued a general warning and a specific warning letter regarding the use of probiotics in pre-term infants. Some products have been linked with more than two dozen reported “adverse events” since 2018Continue Reading FDA issues warnings about probiotics meant for use with premature babies
Abbott Nutrition is recalling certain Similac bottles of formula over a packaging defect.
Early this year, Abbott initiated a large recall of some of its infant formula products and closed its Michigan plant in February…Continue Reading Abbott recalls certain Similac formula over packaging defects
According to press reports, the Food and Drug Administration said on Wednesday it was notified of one more infant death in January potentially related to Abbott Laboratories’ baby formula and the agency has started an…Continue Reading The death of another baby linked to Abbott infant formula apparently under investigation
The infant formula plant that just reopened June 4 after being closed for almost four months because of food safety problems is closed again, this time because of flooding.
Abbott Nutrition’s production plant in Sturgis…Continue Reading Floodwaters force infant formula plant to close down again ‘for a few weeks’
The Food and Drug Administration is investigating a new outbreak of E. coli O157:H7 infections, but little information has been released.
Ten patients have been identified in the E. coli outbreak, but no information has…Continue Reading FDA investigating new outbreak of E. coli O157:H7 infections; 10 people sick
This past week the CDC declared an outbreak of Cronobacter infections over after the FDA received four complaints of Cronobacter infections in infants beginning on September 20, 2021, through January 11, 2022. Two of
The CDC has declared that an outbreak of cronobacter infections among babies is over, but the Food and Drug Administration is continuing its investigation into the maker of the implicated infant formula.
A subcommittee of the U.S. House Energy and Commerce Committee is set to begin a hearing on infant formula shortages, which are related to recalls of products linked to an outbreak of cronobacter infections.
The Food and Drug Administration is allowing Abbott Nutrition to release limited amounts of certain infant formulas made at a plant under investigation in relation to an outbreak of cronobacter infections.
– CONTRIBUTED ANALYSIS –
Editor’s note: This column was originally published in eFoodAlert and is republished here with the author’s permission.
Between Sept. 1, 2019, and Sept. 20, 2021, Abbott Nutrition received 17 consumer complaints…